Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA for painful hypertrophic and keloid scars
2022-000842-14Phase 3Active
- Sponsor
- Dra.Margarita Ramirez&Dra.Ifara Sánchez
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of botulinum toxin type A in Painful scar, Hypertrophic Scar (HS) and keloid, sponsored by Dra.Margarita Ramirez&Dra.Ifara Sánchez. Started Mar 2022; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Painful scarHypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on 2022-000842-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000842-14.